Dr Macdonald has over 20 years of experience in the pharmaceutical industry with extensive knowledge of the dermatology field, both in the USA and throughout the world. He joins Sinclair from Stiefel Laboratories, Inc where he was most recently Vice President, Corporate Development progressing from his role as Vice President Business Development with Connetics Corporation when that company was acquired by Stiefel.
Prior to this Dr Macdonald held the post of Vice President of Research & Development with F.H. Faulding & Co. Limited, an Australian pharmaceutical and healthcare company and was the former Managing Director of Soltec Research, where he led that company's emphasis on dermatology and established its many successful commercial relationships with dermatology companies worldwide. Dr Macdonald has a Ph.D. in biochemistry from Monash University and a postgraduate diploma from the Business School of Swinburne University in Australia.
In his new role, Dr Macdonald will be primarily responsible for developing new commercial opportunities for Sinclair with a particular focus on dermatology products.
Dr Michael Flynn, CEO of Sinclair commented:
"I am very pleased to welcome Dr Ross Macdonald aboard as Vice President Business Development North America & South Pacific.”
“Ross has an excellent track record of success combined with extensive experience in the pharmaceutical industry and knowledge of dermatology. I believe this experience and focus on North America and the South Pacific will further reinforce Sinclair’s internal capabilities and be tremendously valuable for generating growth within this important region.”
